These data strongly suggest that, upon anti-CTLA4 mAb treatment in breast-tumor-bearing mice, LS diet is associated with decreased systemic inflammatory infiltration to lung and diminished pneumonitis, possibly explaining the survival benefit in this cohort. Here, CTLA4 is linked to breast neoplasm.